×
The Investor Relations website contains information about Enanta Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts ...
Investor Resources · Investor FAQs · Email Alerts · RSS Feeds · Contact Us. Events & Presentations. Overview · Press Releases · Events & Presentations · Stock ...
People also ask
The Investor Relations website contains information about Enanta Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts ...
Missing: relations | Show results with:relations
Senior Director of Investor Relations & Corporate Communications, N/A, N/A, N/A. Ms. Tara Lynn Kieffer Ph.D. Senior Vice President of New Product Strategy ...
Get the latest insights on Enanta Pharmaceuticals, Inc. Common Stock (ENTA) with press releases and corporate news to help you in your trading and investing ...
Enanta Pharmaceuticals, Inc. is currently listed on NASDAQ under ENTA. One share of ENTA stock can currently be purchased for approximately $14.00. Is Enanta ...
Missing: relations | Show results with:relations
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Get the latest Enanta Pharmaceuticals, Inc. (ENTA) stock news and headlines to help you in your trading and investing decisions.
Missing: relations | Show results with:relations
Feb 7, 2024 · (ENTA) Q1 2024 Earnings Call Transcript ... Investor Relations. Please go ahead ... High Yield Investor. About ENTA Stock. Symbol, Last Price, % Chg ...
View the latest Enanta Pharmaceuticals Inc. (ENTA) stock price, news, historical charts, analyst ratings and financial information from WSJ.